Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Peptides serve as effective drugs and contrast agents in the clinic today. However the inherent drawbacks of peptide structures can limit their efficacy as drugs. To overcome this we have been developing new methods to create 'tailor-made' peptides and peptide mimetics with improved pharmacological and physical properties. In this work we introduce novel peptide and small molecule conjugated molecules for earlier diagnosis and treatment of melanoma.

Original languageEnglish (US)
Pages (from-to)188-193
Number of pages6
JournalEuropean Journal of Pharmacology
Volume660
Issue number1
DOIs
StatePublished - Jun 11 2011

Keywords

  • Human melanocortin receptors
  • MTII
  • Melanoma
  • Melanotropin
  • Selective ligands for MC receptors
  • THIQ

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma'. Together they form a unique fingerprint.

  • Cite this